Consistent with previous trials showing a reduction in serum IgE levels in patients treated with Dupilumab for CRSwNP, total serum IgE levels decreased continuously until the end of the observation period in our study [11, 19, 25]. This evidence concerns the gene IGHE and chronic rhinosinusitis with nasal polyps.